Immunome, Inc. (IMNM) vs Vericel Corporation (VCEL)

• Immunome, Inc. IMNM 16.47 ▼ −5.34%
• Vericel Corporation VCEL 40.13 ▼ −2.17%

Immunome, Inc. and Vericel Corporation are both Biotechnology companies. Immunome, Inc. and Vericel Corporation are of similar size ($2.1B and $2.1B). Immunome, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 83.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against 16.7%. Vericel Corporation has the higher net margin (7.91% vs 0.00%) and the higher return on invested capital (5.49% vs −3,323.0%). Across the 17 metrics below, Vericel Corporation leads on 14 and Immunome, Inc. on 3.